deferoxamine has been researched along with citric acid, anhydrous in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (32.26) | 18.7374 |
| 1990's | 16 (51.61) | 18.2507 |
| 2000's | 2 (6.45) | 29.6817 |
| 2010's | 3 (9.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Greger, JL; Powers, CF | 1 |
| Goldoni, P; Orsi, N; Pastoris, MC; Valenti, P; Visca, P | 1 |
| Baker, E; Richardson, D | 1 |
| Glennon, JD; Senior, AT | 1 |
| Birchall, JD; Cobbold, PH; Cuthbertson, KS; Dixon, CJ; Lee, JA; Sanchez-Bueno, A; Schöfl, C; Woods, NM | 1 |
| Brown, SJ; Dadparvar, S; Slizofski, WJ | 1 |
| Aruoma, OI; Bell, JD; Bomford, A; Grootveld, M; Halliwell, B; Sadler, PJ | 1 |
| Baum, H; O'Connell, MJ; Peters, TJ; Ward, RJ | 1 |
| Meenakshi, A; Sivanandham, M; Udayachander, M | 1 |
| Hunt, FC | 1 |
| Hoshi, H; Jinnouchi, S; Nagamachi, S; Ono, S; Watanabe, K | 1 |
| Bradley, C; Henderson, AR; Leung, FY; Niblock, AE | 1 |
| Corbella, J; Domingo, JL; Gómez, M; Llobet, JM | 2 |
| Chan, JC; Massie, MD; Santos, F | 1 |
| White, JR; Yeowell, HN | 1 |
| Corbella, J; del Castillo, D; Domingo, JL; Gómez, M; Llobet, JM | 1 |
| Loesberg, AC; Martin, WB | 1 |
| Aust, AE; Chao, CC | 1 |
| Dekker, AW; Keunen, JE; Marx, JJ; Neijt, JP; Nortier, JW; Ros, FE; van Asbeck, BS; Voest, EE | 1 |
| Durbin, PW; Jeung, N; Kullgren, B; Raymond, KN; Rodgers, SJ; Xu, J | 1 |
| Barata, JD; D'Haese, PC; De Broe, ME; Lamberts, LV; Van Landeghem, GF | 1 |
| Ganguly, NK; Gupta, R; Gupta, S; Joshi, K | 1 |
| Baggott, JE; Cornwell, PE; Eto, I; Johanning, GL; Robinson, CB | 1 |
| Hashimoto, K; Hisakawa, N; Matsumori, A; Nishiya, K; Tahara, K | 1 |
| Chiueh, CC; Rauhala, P; Spooner, CM; Van Bergen, P | 1 |
| Ali, A; Dai, J; Huang, X; Zhang, Q | 1 |
| Matinaho, S; Parkkinen, J | 1 |
| Fauser, C; Heilmeier, H; Lodemann, J; Tischler, D; Wiche, O | 1 |
| Lin, Q; Qiu, R; Ruan, D; Wang, S; Wang, Y; Wei, X; Yang, X | 1 |
1 review(s) available for deferoxamine and citric acid, anhydrous
| Article | Year |
|---|---|
Risk factors in aluminum toxicity in children with chronic renal failure.
Topics: Acidosis; Adolescent; Adult; Aluminum; Aluminum Hydroxide; Bone and Bones; Child; Citrates; Citric Acid; Deferoxamine; Humans; Hydrogen-Ion Concentration; Infant; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Risk; Water | 1986 |
1 trial(s) available for deferoxamine and citric acid, anhydrous
| Article | Year |
|---|---|
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Synergism; Eye; Female; Ferric Compounds; Humans; Iron; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sorbitol; Tumor Cells, Cultured | 1993 |
29 other study(ies) available for deferoxamine and citric acid, anhydrous
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats.
Topics: Absorption; Administration, Oral; Aluminum; Animal Feed; Animals; Body Burden; Citrates; Citric Acid; Deferoxamine; Environmental Exposure; Hematocrit; Injections, Intraperitoneal; Iron; Kidney; Liver; Male; Rats; Rats, Sprague-Dawley; Tibia | 1992 |
Growth of Legionella spp. under conditions of iron restriction.
Topics: 2,2'-Dipyridyl; Chelating Agents; Citrates; Citric Acid; Culture Media; Deferoxamine; Iron; Iron Chelating Agents; Legionella; Siderophores; Transferrin | 1991 |
The uptake of inorganic iron complexes by human melanoma cells.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Membrane; Citrates; Citric Acid; Deferoxamine; Humans; Iron; Iron Chelating Agents; Kinetics; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Nitrilotriacetic Acid; Receptors, Transferrin; Transferrin; Tumor Cells, Cultured | 1991 |
Simultaneous determination of desferrioxamine and ferrioxamine by high-performance liquid chromatography with amperometric detection.
Topics: Chromatography, High Pressure Liquid; Citrates; Citric Acid; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Quality Control | 1990 |
Aluminium perturbs oscillatory phosphoinositide-mediated calcium signalling in hormone-stimulated hepatocytes.
Topics: Animals; Calcium; Citrates; Citric Acid; Deferoxamine; Kinetics; Liver; Periodicity; Phenylephrine; Phosphatidylinositols; Rats; Signal Transduction | 1990 |
Altered biodistribution of gallium-67 in a patient with aluminum toxicity treated with desferoxamine.
Topics: Aged; Aluminum; Citrates; Citric Acid; Deferoxamine; Drug Interactions; Gallium Radioisotopes; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Tissue Distribution | 1990 |
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.
Topics: Acetates; Bleomycin; Chlorides; Chromatography, High Pressure Liquid; Citrates; Citric Acid; Deferoxamine; Ferric Compounds; Hemochromatosis; Humans; Iron; Magnetic Resonance Spectroscopy; Transferrin; Ultrafiltration | 1989 |
Iron release from haemosiderin and ferritin by therapeutic and physiological chelators.
Topics: Acetates; Acetic Acid; Animals; Citrates; Citric Acid; Deferoxamine; Ferritins; Hemosiderin; Horses; Humans; Iron; Iron Chelating Agents | 1989 |
Tumor imaging of Dalton's lymphoma using antibody-desferal-Ga-67 complex.
Topics: Animals; Antibodies, Neoplasm; Antigens, Neoplasm; Citrates; Citric Acid; Deferoxamine; Isotope Labeling; Lymphoma; Mice; Radionuclide Imaging | 1989 |
Chelator-induced enhancement of 67Ga tumour imaging: comparison of desferrioxamine with N,N'-ethylene-bis[2-hydroxy-5-carboxyphenylglycine].
Topics: Animals; Chelating Agents; Citrates; Citric Acid; Deferoxamine; Ethylenediamines; Leukemia, Lymphoid; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radionuclide Imaging; Tissue Distribution | 1988 |
Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine.
Topics: Citrates; Citric Acid; Deferoxamine; Female; Gallium Radioisotopes; Hemochromatosis; Humans; Male; Middle Aged; Radionuclide Imaging | 1988 |
Speciation studies of serum aluminum/citrate complex by liquid chromatography-furnace AAS.
Topics: Aluminum; Chromatography, Gel; Chromatography, Liquid; Citrates; Citric Acid; Deferoxamine; Humans; Protein Binding; Spectrophotometry, Atomic; Uremia | 1988 |
Citric, malic and succinic acids as possible alternatives to deferoxamine in aluminum toxicity.
Topics: Aluminum; Animals; Brain Chemistry; Citrates; Citric Acid; Deferoxamine; Feces; Injections, Intraperitoneal; Kidney; Liver; Malates; Male; Mice; Succinates; Succinic Acid | 1988 |
Acute aluminium intoxication: a study of the efficacy of several antidotal treatments in mice.
Topics: Aluminum; Animals; Chelating Agents; Citrates; Citric Acid; Cysteine; Deferoxamine; Lethal Dose 50; Male; Mice; Sodium Salicylate; Tissue Distribution | 1986 |
Iron enhances the bactericidal action of streptonigrin.
Topics: Citrates; Citric Acid; Deferoxamine; Drug Synergism; Escherichia coli; Iron; Puromycin; Species Specificity; Streptonigrin | 1982 |
Comparative aluminium mobilizing actions of several chelators in aluminium-loaded uraemic rats.
Topics: Aluminum; Animals; Chelating Agents; Citrates; Citric Acid; Deferiprone; Deferoxamine; Female; Injections, Intraperitoneal; Pyridones; Rats; Rats, Sprague-Dawley; Succinates; Succinic Acid; Tissue Distribution; Uremia | 1994 |
Altered biodistribution of Ga-67 citrate in an iron-overloaded patient with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Blood Transfusion; Bone and Bones; Citrates; Citric Acid; Deferoxamine; Gallium Radioisotopes; Humans; Iron; Male; Osteomyelitis; Radionuclide Imaging; Tissue Distribution | 1994 |
Effect of long-term removal of iron from asbestos by desferrioxamine B on subsequent mobilization by other chelators and induction of DNA single-strand breaks.
Topics: Asbestos, Amosite; Asbestos, Crocidolite; Citrates; Citric Acid; Deferoxamine; DNA Damage; DNA, Single-Stranded; Edetic Acid; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Kinetics; Time Factors | 1994 |
Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbones.
Topics: Administration, Oral; Animals; Chelating Agents; Citrates; Citric Acid; Deferoxamine; Female; Injections, Intraperitoneal; Mice; Plutonium; Spermine; Tissue Distribution | 1996 |
Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.
Topics: Adult; Aluminum; Citric Acid; Deferoxamine; Female; Humans; Kidney; Male; Middle Aged; Organometallic Compounds; Reference Values; Renal Dialysis; Transferrin | 1997 |
Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis.
Topics: Animals; Chelation Therapy; Chronic Disease; Citric Acid; Deferoxamine; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Ferric Compounds; Free Radicals; Glucosephosphate Dehydrogenase; Glutathione Reductase; Histocytochemistry; Iron; Kidney; L-Lactate Dehydrogenase; Lipid Peroxides; Luminescent Measurements; Mice; Mice, Inbred BALB C; Pyelonephritis; Reactive Oxygen Species; Sorbitol | 1997 |
Iron compounds catalyze the oxidation of 10-formyl-5,6,7,8 tetrahydrofolic acid to 10-formyl-7,8 dihydrofolic acid.
Topics: Animals; Apoproteins; Ascorbic Acid; Cattle; Citric Acid; Deferoxamine; Folic Acid; In Vitro Techniques; Iron Chelating Agents; Iron Compounds; Leucovorin; Oxidation-Reduction; Spectrophotometry, Ultraviolet; Transferrin | 1998 |
Down regulation by iron of prostaglandin E2 production by human synovial fibroblasts.
Topics: Aged; Arthritis, Rheumatoid; Cells, Cultured; Citric Acid; Deferoxamine; Depression, Chemical; Dinoprostone; Dose-Response Relationship, Drug; Female; Ferric Compounds; Fibroblasts; Humans; Interleukin-1; Iron Chelating Agents; Male; Middle Aged; Osteoarthritis, Knee; Recombinant Proteins; Synovial Membrane | 1998 |
Hemoglobin and iron-evoked oxidative stress in the brain: protection by bile pigments, manganese and S-nitrosoglutathione.
Topics: Animals; Antioxidants; Bile Pigments; Bilirubin; Biliverdine; Brain; Citric Acid; Deferoxamine; Ferrous Compounds; Glutathione; Hemoglobins; Iron; Lipid Peroxidation; Male; Manganese; Muscle, Skeletal; Nitroso Compounds; Oxidants; Oxidative Stress; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione; Tissue Extracts | 1999 |
Calcein as a fluorescent iron chemosensor for the determination of low molecular weight iron in biological fluids.
Topics: Body Fluids; Cell Line; Citric Acid; Coal; Deferoxamine; Dust; Fluoresceins; Fluorescence; Fluorescent Dyes; Humans; Iron; Iron Chelating Agents; Molecular Weight; Transferrin | 2003 |
Non-transferrin-bound iron in platelet concentrates promotes the growth of Staphylococcus epidermidis.
Topics: Antimetabolites, Antineoplastic; Bacterial Infections; Bleomycin; Blood Platelets; Citric Acid; Deferoxamine; Iron; Iron Chelating Agents; Plasma; Serum; Staphylococcus epidermidis; Transferrin | 2005 |
Effects of citric acid and the siderophore desferrioxamine B (DFO-B) on the mobility of germanium and rare earth elements in soil and uptake in Phalaris arundinacea.
Topics: Biodegradation, Environmental; Citric Acid; Deferoxamine; Germanium; Phalaris; Siderophores; Soil | 2017 |
Effect of low-molecular-weight organic acids on hematite dissolution promoted by desferrioxamine B.
Topics: Adsorption; Citric Acid; Deferoxamine; Ferric Compounds; Hydrogen-Ion Concentration; Iron; Malates; Molecular Weight; Oxalic Acid; Siderophores; Solubility | 2018 |